Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06621329 · ClinicalTrials.gov registry record · Phase 2
Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache
A Phase 2 study of Headache and SAH (Subarachnoid Hemorrhage), sponsored by University of California, Davis.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06621329 is a Phase 2 study of Headache and SAH (Subarachnoid Hemorrhage) that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 40 participants, below the 154-participant average among 35 other Headache trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06621329, a Phase 2 study of Headache and SAH (Subarachnoid Hemorrhage), is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The study titled \"Transnasal sphenopalatine ganglion block for treatment of acute subarachnoid hemorrhage associated headache\" is a randomized controlled pilot study aimed at evaluating the efficacy of a transnasal sphenopalatine ganglion (SPG) block in addition to standard pain medication for reducing headache severity in patients with acute subarachnoid hemorrhage (aSAH). The study also examines whether this intervention can reduce opioid requirements during hospitalization and upon discharge.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Transnasal sphenopalatine ganglion block
Study Locations (1)
California
- UC Davis Medical Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-10-17 |
| Est. Completion | 2026-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06621329
The ClinicalTrials.gov registry entry for NCT06621329 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 154-participant average among 35 other Headache trials with a reported enrollment target (74% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Headache appearing as the primary indexed condition, and to 1 intervention - of which Transnasal sphenopalatine ganglion block is the first listed.
NCT06621329 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06621329 about?
NCT06621329 is a clinical study titled "Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache". The study titled \"Transnasal sphenopalatine ganglion block for treatment of acute subarachnoid hemorrhage associated headache\" is a randomized controlled pilot study aimed at evaluating the efficacy of a transnasal sphenopalatine ganglion (SPG) block in addition to standard pain medication...
What is the current status of trial NCT06621329?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2024-10-17. Estimated completion is 2026-10.
What conditions does trial NCT06621329 study?
This clinical trial studies the following conditions: Headache, SAH (Subarachnoid Hemorrhage).
What interventions are being tested in trial NCT06621329?
The interventions under investigation include: Transnasal sphenopalatine ganglion block (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06621329?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06621329 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
RECRUITING · Phase 2
-
BLOCK-SAH - PPF-Block for Post-SAH Headache
RECRUITING · Phase 2
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches
RECRUITING
-
Puberty, Testosterone, and Brain Development
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.